FDA Inspection 1158755 — Bloodworks
The FDA completed an inspection of Bloodworks on December 7, 2021 in Lynnwood, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 7, 2021
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Lynnwood, WA (United States)